Cosmos Health Sees FY27 Revenue To Increase By 163%, From $59.35M In 2024 To $155.80M In 2027; Gross Profit To Grow By 653%, From $6.25M In 2024 To $47.06M In 2027; Gross Profit Margin To Expand By 1,970 Basis Points, From 10.50% In 2024 To 30.20% In...
Cosmos Health Sees FY27 Revenue To Increase By 163%, From $59.35M In 2024 To $155.80M In 2027; Gross Profit To Grow By 653%, From $6.25M In 2024 To $47.06M In 2027; Gross Profit Margin To Expand By 1,970 Basis Points, From 10.50% In 2024 To 30.20% In...
阿童木健康預計2027財年營業收入將增長163%，從2024年的5935萬增加到2027年的15580萬；毛利潤將增長653%，從2024年的625萬增加到2027年的4706萬；毛利潤率將擴大1970個點子，從2024年的10.50%增加到2027年的30.20%...
Cosmos Health Sees FY27 Revenue To Increase By 163%, From $59.35M In 2024 To $155.80M In 2027; Gross Profit To Grow By 653%, From $6.25M In 2024 To $47.06M In 2027; Gross Profit Margin To Expand By 1,970 Basis Points, From 10.50% In 2024 To 30.20% In 2027; Net Income To Increase By 402%, Reaching $20.44M In 2027, Compared To A Loss Of $6.76M In 2024; Adjusted EBITDA To Grow To $29.40M In 2027, From A Loss Of $1.21M In 2024.
阿童木健康預計2027財年營業收入將增長163%，從2024年的5935萬美元增加到2027年的15580萬美元；毛利潤將增長653%，從2024年的625萬美元增加到2027年的4706萬美元；毛利潤率將增加1970個點子，從2024年的10.50%增加到2027年的30.20%；淨利潤將增長402%，達到2027年的2044萬美元，而2024年爲虧損676萬美元；調整後的EBITDA將從2024年的121萬美元虧損增長至2027年的2940萬美元。
Updated Financial Guidance
更新後的財務指導方針
We are pleased to see the pieces of our multi-year strategy coming together, which has made us confident in communicating our 2024-2027 guidance. By 2027, we anticipate substantial value creation by achieving the following:
我們很高興看到我們跨年度策略的各個部分正在融合在一起，這讓我們對溝通我們的2024年至2027年指導方針充滿信心。到2027年，我們預計通過實現以下目標實現大量價值創造：
Revenue to increase by 163%, from $59.35 million in 2024 to...
營業收入將增長1...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間